Early loss of immunity against measles following allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Early loss of immunity against measles following allogeneic hematopoietic stem cell transplantation

Published:2019-08-16 Issue:10 Volume:94 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Garcia Garrido Hannah M.¹²^ORCID,Aalst Mariëlle¹²,Schinkel Janke³,Koen Gerrit³,Defoer Jacqueline M.³,Hazenberg Mette D.⁴,Nur Erfan⁴,Grobusch Martin P.¹²,Zeerleder Sascha S.⁴⁵⁶⁷,Goorhuis Abraham¹²,Bree Godelieve J.¹²⁸

Affiliation:

1. Department of Infectious DiseasesAmsterdam UMC‐location AMC, The Amsterdam Infection and Immunity Institute (AI&II), University of Amsterdam Amsterdam The Netherlands

2. Center for Tropical Medicine and Travel Medicine, Amsterdam UMC‐Location AMCThe Amsterdam Infection & Immunity Institute (AI&II), University of Amsterdam Amsterdam The Netherlands

3. Department of Medical Microbiology, Clinical VirologyAmsterdam UMC‐location AMC, University of Amsterdam Amsterdam The Netherlands

4. Department of HematologyAmsterdam UMC‐location AMC, University of Amsterdam, and Cancer Center Amsterdam, University of Amsterdam Amsterdam The Netherlands

5. Department of Immunopathology, Sanquin ResearchAmsterdam UMC‐location AMC, The Amsterdam Infection & Immunity Institute (AI&II), University of Amsterdam Amsterdam The Netherlands

6. Department of Hematology and Central Hematology LaboratoryInselspital, Bern University Hospital and Department for BioMedical Research, University of Bern Bern Switzerland

7. Department for BioMedical ResearchUniversity of Bern Bern Switzerland

8. Amsterdam Institute for Global Health and Development Amsterdam The Netherlands

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25590

Reference6 articles.

1. Severe Measles in Immunocompromised Patients

2. WHO. Global Measles and Rubella. Published November 2018.http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/Global_MR_Update_November_2018.pdf. Accessed: November 22 2018.

3. Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease

4. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation

5. WHO International Standard 3rd International Standard for Anti‐Measles NIBSC code: 97/648 (Version 2.0 Dated February 26 2008).

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunity Against Measles in Korean Autologous Hematopoietic Stem Cell Transplant Recipients;Journal of Korean Medical Science;2024

2. COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy;Transplant Infectious Disease;2023-09-28

3. Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination;Cancers;2023-04-18

4. Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant;Open Forum Infectious Diseases;2021-11-23

5. Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients;Vaccine;2021-06